NORTH AMERICA SURGICAL/OPERATING MICROSCOPES MARKET FORECAST 2018-2026
KEY FINDINGS
A leading region in the global surgical/operating microscope market is North America. The region contributed the highest revenue in 2017. Also, by the end of the forecast period of 2018-2026, the North America surgical/operating microscope market is likely to flourish at a 9.66% CAGR.
MARKET INSIGHTS
Factors such as increased adoption of fluorescent image-guided surgery (FIGS), increasing number of cosmetic surgeries and customized solutions for microscopy are contributing to this market’s growth. US and Canada are the key regions analyzed for this market, with the US contributing the highest revenue in 2017. However, heavy customs duties on medical devices and excise taxes imposed by the US government are restraining the North America surgical/operating microscope market’s growth.
COMPETITIVE INSIGHTS
Companies such as Gem Optical Instruments Industries, Danaher Corporation, Alltion Co. Ltd., Topcon Corporation, Karl Kaps Gmbh, Ari Medical Equipment Co Ltd, Olympus Corporation, Seiler Precision Microscopes, Orion Medic, Novartis International Ag and Carl Zeiss Ag are operating in the North American surgical/operating microscope market.
A leading region in the global surgical/operating microscope market is North America. The region contributed the highest revenue in 2017. Also, by the end of the forecast period of 2018-2026, the North America surgical/operating microscope market is likely to flourish at a 9.66% CAGR.
MARKET INSIGHTS
Factors such as increased adoption of fluorescent image-guided surgery (FIGS), increasing number of cosmetic surgeries and customized solutions for microscopy are contributing to this market’s growth. US and Canada are the key regions analyzed for this market, with the US contributing the highest revenue in 2017. However, heavy customs duties on medical devices and excise taxes imposed by the US government are restraining the North America surgical/operating microscope market’s growth.
COMPETITIVE INSIGHTS
Companies such as Gem Optical Instruments Industries, Danaher Corporation, Alltion Co. Ltd., Topcon Corporation, Karl Kaps Gmbh, Ari Medical Equipment Co Ltd, Olympus Corporation, Seiler Precision Microscopes, Orion Medic, Novartis International Ag and Carl Zeiss Ag are operating in the North American surgical/operating microscope market.
1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
3.2.1. NORTH AMERICA DOMINATES THE GLOBAL SURGICAL/OPERATING MICROSCOPES MARKET
3.2.2. OPHTHALMOLOGY HOLDS MAJOR CHUNK OF THE APPLICATION SEGMENT
3.2.3. ON-CASTERS MICROSCOPES LEADS THE MARKET BY TYPE
4. MARKET DYNAMICS
4.1. MARKET DEFINITION
4.2. DRIVERS
4.2.1. INCREASED ADOPTION OF FLUORESCENT IMAGE GUIDED SURGERY (FIGS)
4.2.2. INCREASING NUMBER OF SURGERIES AND GROWING DEMAND FOR MIS
4.2.3. CUSTOMIZED SOLUTIONS FOR MICROSCOPY
4.2.4. RISING HEALTHCARE EXPENDITURE
4.2.5. RISING GERIATRIC POPULATION
4.3. RESTRAINTS
4.3.1. HEAVY CUSTOM DUTIES ON MEDICAL DEVICES
4.3.2. EXCISE TAX BY US GOVERNMENT
4.4. OPPORTUNITIES
4.4.1. WIDE RANGE OF APPLICATIONS OF OPERATING MICROSCOPES
4.4.2. TECHNOLOGICAL ADVANCEMENT
4.5. CHALLENGES
4.5.1. LACK OF SKILLED PROFESSIONALS
4.5.2. HIGH COST OF ADVANCED OPERATING MICROSCOPES
5. MARKET BY TYPE
5.1. ON CASTERS MICROSCOPE
5.2. WALL MOUNTED MICROSCOPE
5.3. Table TOP MICROSCOPE
5.4. CEILING MOUNTED MICROSCOPE
6. MARKET BY APPLICATION
6.1. NEURO AND SPINE SURGERY
6.2. PLASTIC AND RECONSTRUCTIVE SURGERY
6.3. OPHTHALMOLOGY
6.4. ENT SURGERY
6.5. ONCOLOGY
6.6. GYNAECOLOGY AND UROLOGY
6.7. OTHER
7. MARKET BY END-USER
7.1. HOSPITALS
7.2. PHYSICIAN/DENTIST
7.3. OTHER OUTPATIENT FACILITIES
8. KEY ANALYTICS
8.1. PORTER’S 5 FORCE MODEL
8.1.1. THREAT OF NEW ENTRANTS
8.1.2. THREAT OF SUBSTITUTE PRODUCTS
8.1.3. BARGAINING POWER OF BUYERS
8.1.4. BARGAINING POWER SUPPLIERS
8.1.5. INTENSITY OF COMPETITIVE RIVALRY
8.2. KEY BUYING CRITERIA
8.2.1. APPLICATION
8.2.2. COST
8.2.3. MAGNIFICATION
8.2.4. INNOVATION
8.3. VALUE CHAIN ANALYSIS
8.3.1. RAW MATERIAL SUPPLIERS
8.3.2. MANUFACTURERS
8.3.3. DISTRIBUTORS
8.3.4. END-USER
8.4. REGULATORY FRAMEWORK
8.5. INVESTMENT OUTLOOK
8.5.1. APPLICATIONS OUTLOOK
8.6. VENDOR LANDSCAPE
8.7. OPPORTUNITY MATRIX
9. GEOGRAPHICAL ANALYSIS
9.1. UNITED STATES
9.2. CANADA
10. COMPETITIVE LANDSCAPE
10.1. MARKET SHARE ANALYSIS
10.1.1. CARL ZEISS (GERMANY)
10.1.2. DANAHER CORP. (US)
10.1.3. NOVARTIS (SWITZERLAND)
10.1.4. TOPCON CORP. (JAPAN)
10.1.5. HAAG-STREIT SURGICAL (GERMANY)
10.2. CORPORATE STRATEGIES
10.3. COMPANY PROFILES
10.3.1. DANAHER CORPORATION
10.3.1.1. OVERVIEW
10.3.1.2. PRODUCT PORTFOLIO
10.3.1.3. STRATEGIC INITIATIVE
10.3.1.4. SCOT ANALYSIS
10.3.1.5. STRATEGIC ANALYSIS
10.3.2. NOVARTIS INTERNATIONAL AG
10.3.2.1. OVERVIEW
10.3.2.2. PRODUCT PORTFOLIO
10.3.2.3. STRATEGIC INITIATIVES
10.3.2.4. SCOT ANALYSIS
10.3.2.5. STRATEGIC ANALYSIS
10.3.3. CHAMMED CO.LTD.
10.3.3.1. OVERVIEW
10.3.3.2. PRODUCTS PORTFOLIO
10.3.3.3. SCOT ANALYSIS
10.3.3.4. STRATEGIC ANALYSIS
10.3.4. NORTH AMERICA SURGICAL CORPORATION
10.3.4.1. OVERVIEW
10.3.4.2. PRODUCT PORTFOLIO
10.3.4.3. STRATEGIC INITIATIVE
10.3.4.4. SCOT ANALYSIS
10.3.4.5. STRATEGIC ANALYSIS
10.3.5. SEILER PRECISION MICROSCOPES
10.3.5.1. OVERVIEW
10.3.5.2. PRODUCT PORTFOLIO
10.3.5.3. SCOT ANALYSIS
10.3.5.4. STRATEGIC ANALYSIS
10.3.6. TAKAGI SEIKO CO. LTD.
10.3.6.1. OVERVIEW
10.3.6.2. PRODUCT PORTFOLIO
10.3.6.3. SCOT ANALYSIS
10.3.6.4. STRATEGIC ANALYSIS
10.3.7. ORION MEDIC
10.3.7.1. OVERVIEW
10.3.7.2. PRODUCT PORTFOLIO
10.3.7.3. SCOT ANALYSIS
10.3.7.4. STRATEGIC ANALYSIS
10.3.8. KARL KAPS GMBH
10.3.8.1. OVERVIEW
10.3.8.2. PRODUCT PORTFOLIO
10.3.8.3. SCOT ANALYSIS
10.3.8.4. STRATEGIC ANALYSIS
10.3.9. OLYMPUS CORPORATION
10.3.9.1. OVERVIEW
10.3.9.2. PRODUCT PORTFOLIO
10.3.9.3. STRATEGIC INITIATIVES
10.3.9.4. SCOT ANALYSIS
10.3.9.5. STRATEGIC ANALYSIS
10.3.10. TOPCON CORPORATION
10.3.10.1. OVERVIEW
10.3.10.2. PRODUCT PORTFOLIO
10.3.10.3. STRATEGIC INITIATIVES
10.3.10.4. SCOT ANALYSIS
10.3.10.5. STRATEGIC ANALYSIS
10.3.11. CARL ZEISS AG
10.3.11.1. OVERVIEW
10.3.11.2. PRODUCT PORTFOLIO
10.3.11.3. STRATEGIC INITIATIVES
10.3.11.4. SCOT ANALYSIS
10.3.11.5. STRATEGIC ANALYSIS
10.3.12. HAAG-STREIT SURGICAL GMBH
10.3.12.1. OVERVIEW
10.3.12.2. PRODUCT PORTFOLIO
10.3.12.3. SCOT ANALYSIS
10.3.12.4. STRATEGIC ANALYSIS
10.3.13. GEM OPTICAL INSTRUMENTS INDUSTRIES
10.3.13.1. OVERVIEW
10.3.13.2. PRODUCT PORTFOLIO
10.3.13.3. SCOT ANALYSIS
10.3.13.4. STRATEGIC ANALYSIS
10.3.14. ALLTION CO. LTD.
10.3.14.1. OVERVIEW
10.3.14.2. PRODUCT PORTFOLIO
10.3.14.3. SCOT ANALYSIS
10.3.14.4. STRATEGIC ANALYSIS
10.3.15. ARI MEDICAL EQUIPMENT CO., LTD.
10.3.15.1. OVERVIEW
10.3.15.2. PRODUCT PORTFOLIO
10.3.15.3. SCOT ANALYSIS
10.3.15.4. STRATEGIC ANALYSIS
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
3.2.1. NORTH AMERICA DOMINATES THE GLOBAL SURGICAL/OPERATING MICROSCOPES MARKET
3.2.2. OPHTHALMOLOGY HOLDS MAJOR CHUNK OF THE APPLICATION SEGMENT
3.2.3. ON-CASTERS MICROSCOPES LEADS THE MARKET BY TYPE
4. MARKET DYNAMICS
4.1. MARKET DEFINITION
4.2. DRIVERS
4.2.1. INCREASED ADOPTION OF FLUORESCENT IMAGE GUIDED SURGERY (FIGS)
4.2.2. INCREASING NUMBER OF SURGERIES AND GROWING DEMAND FOR MIS
4.2.3. CUSTOMIZED SOLUTIONS FOR MICROSCOPY
4.2.4. RISING HEALTHCARE EXPENDITURE
4.2.5. RISING GERIATRIC POPULATION
4.3. RESTRAINTS
4.3.1. HEAVY CUSTOM DUTIES ON MEDICAL DEVICES
4.3.2. EXCISE TAX BY US GOVERNMENT
4.4. OPPORTUNITIES
4.4.1. WIDE RANGE OF APPLICATIONS OF OPERATING MICROSCOPES
4.4.2. TECHNOLOGICAL ADVANCEMENT
4.5. CHALLENGES
4.5.1. LACK OF SKILLED PROFESSIONALS
4.5.2. HIGH COST OF ADVANCED OPERATING MICROSCOPES
5. MARKET BY TYPE
5.1. ON CASTERS MICROSCOPE
5.2. WALL MOUNTED MICROSCOPE
5.3. Table TOP MICROSCOPE
5.4. CEILING MOUNTED MICROSCOPE
6. MARKET BY APPLICATION
6.1. NEURO AND SPINE SURGERY
6.2. PLASTIC AND RECONSTRUCTIVE SURGERY
6.3. OPHTHALMOLOGY
6.4. ENT SURGERY
6.5. ONCOLOGY
6.6. GYNAECOLOGY AND UROLOGY
6.7. OTHER
7. MARKET BY END-USER
7.1. HOSPITALS
7.2. PHYSICIAN/DENTIST
7.3. OTHER OUTPATIENT FACILITIES
8. KEY ANALYTICS
8.1. PORTER’S 5 FORCE MODEL
8.1.1. THREAT OF NEW ENTRANTS
8.1.2. THREAT OF SUBSTITUTE PRODUCTS
8.1.3. BARGAINING POWER OF BUYERS
8.1.4. BARGAINING POWER SUPPLIERS
8.1.5. INTENSITY OF COMPETITIVE RIVALRY
8.2. KEY BUYING CRITERIA
8.2.1. APPLICATION
8.2.2. COST
8.2.3. MAGNIFICATION
8.2.4. INNOVATION
8.3. VALUE CHAIN ANALYSIS
8.3.1. RAW MATERIAL SUPPLIERS
8.3.2. MANUFACTURERS
8.3.3. DISTRIBUTORS
8.3.4. END-USER
8.4. REGULATORY FRAMEWORK
8.5. INVESTMENT OUTLOOK
8.5.1. APPLICATIONS OUTLOOK
8.6. VENDOR LANDSCAPE
8.7. OPPORTUNITY MATRIX
9. GEOGRAPHICAL ANALYSIS
9.1. UNITED STATES
9.2. CANADA
10. COMPETITIVE LANDSCAPE
10.1. MARKET SHARE ANALYSIS
10.1.1. CARL ZEISS (GERMANY)
10.1.2. DANAHER CORP. (US)
10.1.3. NOVARTIS (SWITZERLAND)
10.1.4. TOPCON CORP. (JAPAN)
10.1.5. HAAG-STREIT SURGICAL (GERMANY)
10.2. CORPORATE STRATEGIES
10.3. COMPANY PROFILES
10.3.1. DANAHER CORPORATION
10.3.1.1. OVERVIEW
10.3.1.2. PRODUCT PORTFOLIO
10.3.1.3. STRATEGIC INITIATIVE
10.3.1.4. SCOT ANALYSIS
10.3.1.5. STRATEGIC ANALYSIS
10.3.2. NOVARTIS INTERNATIONAL AG
10.3.2.1. OVERVIEW
10.3.2.2. PRODUCT PORTFOLIO
10.3.2.3. STRATEGIC INITIATIVES
10.3.2.4. SCOT ANALYSIS
10.3.2.5. STRATEGIC ANALYSIS
10.3.3. CHAMMED CO.LTD.
10.3.3.1. OVERVIEW
10.3.3.2. PRODUCTS PORTFOLIO
10.3.3.3. SCOT ANALYSIS
10.3.3.4. STRATEGIC ANALYSIS
10.3.4. NORTH AMERICA SURGICAL CORPORATION
10.3.4.1. OVERVIEW
10.3.4.2. PRODUCT PORTFOLIO
10.3.4.3. STRATEGIC INITIATIVE
10.3.4.4. SCOT ANALYSIS
10.3.4.5. STRATEGIC ANALYSIS
10.3.5. SEILER PRECISION MICROSCOPES
10.3.5.1. OVERVIEW
10.3.5.2. PRODUCT PORTFOLIO
10.3.5.3. SCOT ANALYSIS
10.3.5.4. STRATEGIC ANALYSIS
10.3.6. TAKAGI SEIKO CO. LTD.
10.3.6.1. OVERVIEW
10.3.6.2. PRODUCT PORTFOLIO
10.3.6.3. SCOT ANALYSIS
10.3.6.4. STRATEGIC ANALYSIS
10.3.7. ORION MEDIC
10.3.7.1. OVERVIEW
10.3.7.2. PRODUCT PORTFOLIO
10.3.7.3. SCOT ANALYSIS
10.3.7.4. STRATEGIC ANALYSIS
10.3.8. KARL KAPS GMBH
10.3.8.1. OVERVIEW
10.3.8.2. PRODUCT PORTFOLIO
10.3.8.3. SCOT ANALYSIS
10.3.8.4. STRATEGIC ANALYSIS
10.3.9. OLYMPUS CORPORATION
10.3.9.1. OVERVIEW
10.3.9.2. PRODUCT PORTFOLIO
10.3.9.3. STRATEGIC INITIATIVES
10.3.9.4. SCOT ANALYSIS
10.3.9.5. STRATEGIC ANALYSIS
10.3.10. TOPCON CORPORATION
10.3.10.1. OVERVIEW
10.3.10.2. PRODUCT PORTFOLIO
10.3.10.3. STRATEGIC INITIATIVES
10.3.10.4. SCOT ANALYSIS
10.3.10.5. STRATEGIC ANALYSIS
10.3.11. CARL ZEISS AG
10.3.11.1. OVERVIEW
10.3.11.2. PRODUCT PORTFOLIO
10.3.11.3. STRATEGIC INITIATIVES
10.3.11.4. SCOT ANALYSIS
10.3.11.5. STRATEGIC ANALYSIS
10.3.12. HAAG-STREIT SURGICAL GMBH
10.3.12.1. OVERVIEW
10.3.12.2. PRODUCT PORTFOLIO
10.3.12.3. SCOT ANALYSIS
10.3.12.4. STRATEGIC ANALYSIS
10.3.13. GEM OPTICAL INSTRUMENTS INDUSTRIES
10.3.13.1. OVERVIEW
10.3.13.2. PRODUCT PORTFOLIO
10.3.13.3. SCOT ANALYSIS
10.3.13.4. STRATEGIC ANALYSIS
10.3.14. ALLTION CO. LTD.
10.3.14.1. OVERVIEW
10.3.14.2. PRODUCT PORTFOLIO
10.3.14.3. SCOT ANALYSIS
10.3.14.4. STRATEGIC ANALYSIS
10.3.15. ARI MEDICAL EQUIPMENT CO., LTD.
10.3.15.1. OVERVIEW
10.3.15.2. PRODUCT PORTFOLIO
10.3.15.3. SCOT ANALYSIS
10.3.15.4. STRATEGIC ANALYSIS
LIST OF TABLES
Table 1 NORTH AMERICA SURGICAL/OPERATING MICROSCOPES MARKET BY COUNTRY 2018-2026 ($ MILLION)
Table 2 PREVALENCE OF EYE DISEASES IN US 2014-2030
Table 3 EVOLUTION OF SURGICAL/OPERATING MICROSCOPE
Table 4 FDA APPROVALS FOR FLUORESCENCE IMAGING SYSTEM
Table 5 BENEFITS OF MINIMALLY INVASIVE SURGERY
Table 6 NUMBER OF PHYSICIANS PER 10,000 POPULATION
Table 7 SURGICAL/OPERATING MICROSCOPES PRICE RANGE
Table 8 NORTH AMERICA SURGICAL/OPERATING MARKET BY TYPE 2018-2026 ($ MILLION)
Table 9 NORTH AMERICA SURGICAL/OPERATING MICROSCOPE MARKET BY APPLICATION 2018-2026 ($ MILLION)
Table 10 NORTH AMERICA SURGICAL/OPERATING MICROSCOPE MARKET BY END-USER 2018-2026 ($ MILLION)
Table 11 REGULATORY FRAMEWORK
Table 12 NORTH AMERICA SURGICAL/OPERATING MICROSCOPE MARKET BY COUNTRY 2018-2026 ($ MILLION)
Table 1 NORTH AMERICA SURGICAL/OPERATING MICROSCOPES MARKET BY COUNTRY 2018-2026 ($ MILLION)
Table 2 PREVALENCE OF EYE DISEASES IN US 2014-2030
Table 3 EVOLUTION OF SURGICAL/OPERATING MICROSCOPE
Table 4 FDA APPROVALS FOR FLUORESCENCE IMAGING SYSTEM
Table 5 BENEFITS OF MINIMALLY INVASIVE SURGERY
Table 6 NUMBER OF PHYSICIANS PER 10,000 POPULATION
Table 7 SURGICAL/OPERATING MICROSCOPES PRICE RANGE
Table 8 NORTH AMERICA SURGICAL/OPERATING MARKET BY TYPE 2018-2026 ($ MILLION)
Table 9 NORTH AMERICA SURGICAL/OPERATING MICROSCOPE MARKET BY APPLICATION 2018-2026 ($ MILLION)
Table 10 NORTH AMERICA SURGICAL/OPERATING MICROSCOPE MARKET BY END-USER 2018-2026 ($ MILLION)
Table 11 REGULATORY FRAMEWORK
Table 12 NORTH AMERICA SURGICAL/OPERATING MICROSCOPE MARKET BY COUNTRY 2018-2026 ($ MILLION)
LIST OF FIGURES
Figure 1 NORTH AMERICA SURGICAL/OPERATING MICROSCOPES MARKET BY APPLICATION 2018-2026 ($ MILLION)
Figure 2 NORTH AMERICA SURGICAL/OPERATING MICROSCOPES MARKET 2018-2026 ($ MILLION)
Figure 3 NORTH AMERICA OPHTHALMOLOGY MARKET 2018-2026 ($ MILLION)
Figure 4 NORTH AMERICA ON-CASTER MICROSCOPES MARKET 2018-2026 ($ MILLION)
Figure 5 NUMBER OF CATARACT SURGERIES PERFORMED
Figure 6 TOP 3 COSMETIC MINIMALLY INVASIVE PROCEDURES IN THE US (IN MILLIONS)
Figure 7 HEALTHCARE EXPENDITURE ACROSS REGIONS 2014-2015 (% OF GDP)
Figure 8 HEALTHCARE EXPENDITURE IN THE US 2015-2025 (% OF GDP)
Figure 9 PERCENTAGE DISTRIBUTION OF POPULATION AGED 65 YEARS AND ABOVE BY REGION FOR PERIOD 2016-2050
Figure 10 NORTH AMERICA ON CASTERS MICROSCOPE MARKET 2018-2026 ($ MILLION)
Figure 11 NORTH AMERICA WALL MOUNTED MICROSCOPE MARKET 2018-2026 ($ MILLION)
Figure 12 NORTH AMERICA Table TOP MICROSCOPE MARKET 2018-2026 ($ MILLION)
Figure 13 NORTH AMERICA CEILING MOUNTED MICROSCOPE MARKET 2018-2026 ($ MILLION)
Figure 14 NORTH AMERICA NEURO AND SPINE SURGERY MARKET 2018-2026 ($ MILLION)
Figure 15 NORTH AMERICA PLASTIC AND RECONSTRUCTIVE SURGERY MARKET 2018-2026 ($ MILLION)
Figure 16 NORTH AMERICA OPHTHALMOLOGY MARKET 2018-2026 ($ MILLION)
Figure 17 NORTH AMERICA ENT SURGERY MARKET 2018-2026 ($ MILLION)
Figure 18 NORTH AMERICA ONCOLOGY MARKET 2018-2026 ($ MILLION)
Figure 19 NORTH AMERICA GYNAECOLOGY AND UROLOGY MARKET 2018-2026 ($ MILLION)
Figure 20 NORTH AMERICA OTHER MARKET 2018-2026 ($ MILLION)
Figure 21 NORTH AMERICA HOSPITALS MARKET 2018-2026 ($ MILLION)
Figure 22 NORTH AMERICA PHYSICIAN/DENTIST MARKET 2018-2026 ($ MILLION)
Figure 23 NORTH AMERICA OTHER OUTPATIENT FACILITIES MARKET 2018-2026 ($ MILLION)
Figure 24 INVESTMENT PROPOSITION FOR NORTH AMERICA SURGICAL/OPERATING MICROSCOPES MARKET BY APPLICATIONS – 2017
Figure 25 UNITED STATES SURGICAL/OPERATING MICROSCOPE MARKET 2018-2026 ($ MILLION)
Figure 26 CANADA SURGICAL/OPERATING MICROSCOPE MARKET 2018-2026 ($ MILLION)
Figure 27 MARKET SHARE ANALYSIS OF NORTH AMERICA SURGICAL/OPERATING MICROSCOPES MARKET – 2017 (%)
Figure 1 NORTH AMERICA SURGICAL/OPERATING MICROSCOPES MARKET BY APPLICATION 2018-2026 ($ MILLION)
Figure 2 NORTH AMERICA SURGICAL/OPERATING MICROSCOPES MARKET 2018-2026 ($ MILLION)
Figure 3 NORTH AMERICA OPHTHALMOLOGY MARKET 2018-2026 ($ MILLION)
Figure 4 NORTH AMERICA ON-CASTER MICROSCOPES MARKET 2018-2026 ($ MILLION)
Figure 5 NUMBER OF CATARACT SURGERIES PERFORMED
Figure 6 TOP 3 COSMETIC MINIMALLY INVASIVE PROCEDURES IN THE US (IN MILLIONS)
Figure 7 HEALTHCARE EXPENDITURE ACROSS REGIONS 2014-2015 (% OF GDP)
Figure 8 HEALTHCARE EXPENDITURE IN THE US 2015-2025 (% OF GDP)
Figure 9 PERCENTAGE DISTRIBUTION OF POPULATION AGED 65 YEARS AND ABOVE BY REGION FOR PERIOD 2016-2050
Figure 10 NORTH AMERICA ON CASTERS MICROSCOPE MARKET 2018-2026 ($ MILLION)
Figure 11 NORTH AMERICA WALL MOUNTED MICROSCOPE MARKET 2018-2026 ($ MILLION)
Figure 12 NORTH AMERICA Table TOP MICROSCOPE MARKET 2018-2026 ($ MILLION)
Figure 13 NORTH AMERICA CEILING MOUNTED MICROSCOPE MARKET 2018-2026 ($ MILLION)
Figure 14 NORTH AMERICA NEURO AND SPINE SURGERY MARKET 2018-2026 ($ MILLION)
Figure 15 NORTH AMERICA PLASTIC AND RECONSTRUCTIVE SURGERY MARKET 2018-2026 ($ MILLION)
Figure 16 NORTH AMERICA OPHTHALMOLOGY MARKET 2018-2026 ($ MILLION)
Figure 17 NORTH AMERICA ENT SURGERY MARKET 2018-2026 ($ MILLION)
Figure 18 NORTH AMERICA ONCOLOGY MARKET 2018-2026 ($ MILLION)
Figure 19 NORTH AMERICA GYNAECOLOGY AND UROLOGY MARKET 2018-2026 ($ MILLION)
Figure 20 NORTH AMERICA OTHER MARKET 2018-2026 ($ MILLION)
Figure 21 NORTH AMERICA HOSPITALS MARKET 2018-2026 ($ MILLION)
Figure 22 NORTH AMERICA PHYSICIAN/DENTIST MARKET 2018-2026 ($ MILLION)
Figure 23 NORTH AMERICA OTHER OUTPATIENT FACILITIES MARKET 2018-2026 ($ MILLION)
Figure 24 INVESTMENT PROPOSITION FOR NORTH AMERICA SURGICAL/OPERATING MICROSCOPES MARKET BY APPLICATIONS – 2017
Figure 25 UNITED STATES SURGICAL/OPERATING MICROSCOPE MARKET 2018-2026 ($ MILLION)
Figure 26 CANADA SURGICAL/OPERATING MICROSCOPE MARKET 2018-2026 ($ MILLION)
Figure 27 MARKET SHARE ANALYSIS OF NORTH AMERICA SURGICAL/OPERATING MICROSCOPES MARKET – 2017 (%)
